Breaking News Instant updates and real-time market news.

INCY

Incyte

$64.02

-19.05 (-22.93%)

15:45
04/09/18
04/09
15:45
04/09/18
15:45

Incyte call volume above normal and directionally bullish

Bullish option flow detected in Incyte with 18,210 calls trading, 4x expected, and implied vol increasing almost 2 points to 53.94%. Jun-18 80 calls and Jun-18 105 calls are the most active options, with total volume in those strikes near 10,300 contracts. The Put/Call Ratio is 0.42. Earnings are expected on May 3rd.

  • 23

    Apr

  • 12

    Jun

INCY Incyte
$64.02

-19.05 (-22.93%)

04/09/18
04/09/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Westlake Chemical (WLK) downgraded to Neutral from Overweight at JPMorgan with analyst Jeffrey Zekauskas citing valuation. 2. Mettler-Toledo (MTD) downgraded to Neutral from Buy at Goldman Sachs with analyst Patrick Donnelly saying he sees an attractive fundamental backdrop across Tools but is more cautious on the outlook for sales upside at Mettler given his view of a likely moderation of growth in China after a year of catch-up investment in the region. Donnelly also highlights "tough comps" in Labs and Product inspection. 3. Franklin Resources (BEN) downgraded to Neutral from Buy at BofA/Merrill with analyst Michael Carrier saying Franklin's bottom half performance and continued outflows limits organic growth and multiple expansion. 4. NewLink Genetics (NLNK) downgraded to Neutral from Overweight at Cantor Fitzgerald and Baird as well as to Hold from Buy at Jefferies. 5. Incyte (INCY) downgraded to Hold from Buy at Gabelli with analyst Jing He citing the "surprising" failure of the Phase 3 ECHO-301 study in melanoma. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/09/18
RHCO
04/09/18
NO CHANGE
Target $80
RHCO
Buy
Incyte price target lowered to $80 from $155 at SunTrust
SunTrust analyst Peter Lawson slashed his price target on Incyte to $80 after the failure of phase 3 IDO study in melanoma, saying that he is removing all IDO indicators from his model while also sharply discounting the post-IDO pipeline. While the analyst warns that further negative news related to IDO readouts could be coming, the post-failure stock price decline does create some "underlying value", keeping his Buy rating on Incyte.
04/09/18
GABE
04/09/18
DOWNGRADE
GABE
Hold
Incyte downgraded to Hold from Buy at Gabelli
Gabelli analyst Jing He downgraded Incyte to Hold following the "surprising" failure of the Phase 3 ECHO-301 study in melanoma. The analyst remains positive on Jakafi's long-term growth and estimates peak sales of $2.7B but recommends staying on the sideline before baricitinib Adcom on April 23.
04/09/18
BARD
04/09/18
DOWNGRADE
Target $5
BARD
Neutral
NewLink Genetics downgraded to Neutral at Baird
As reported previously, Baird analyst Michael Ulz downgraded NewLink Genetics (NLNK) to Neutral from Outperform. The analyst cited the disappointing results from Incyte's (INCY) Phase-3 ECHO-301 study in melanoma. Given the uncertainty surrounding the opportunity after NewLink said it will revisit the indoximod clinical program following Incyte's news, Ulz lowered his price target to $5 from $22 on NewLink Genetics shares.

TODAY'S FREE FLY STORIES

KSS

Kohl's

$65.28

0.83 (1.29%)

10:40
11/21/18
11/21
10:40
11/21/18
10:40
Options
Bullish call spread in Kohls after recent weakness in shares »

Bullish call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:40
11/21/18
11/21
10:40
11/21/18
10:40
General news
The U.S. 1.4% October existing home sales rise »

The U.S. 1.4% October…

10:40
11/21/18
11/21
10:40
11/21/18
10:40
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

DE

Deere

$145.63

7.14 (5.16%)

10:37
11/21/18
11/21
10:37
11/21/18
10:37
Hot Stocks
Breaking Hot Stocks news story on Deere »

Deere raises 2022…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

DE

Deere

$144.30

5.81 (4.20%)

10:32
11/21/18
11/21
10:32
11/21/18
10:32
Hot Stocks
Breaking Hot Stocks news story on Deere »

Deere sees grain demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

10:31
11/21/18
11/21
10:31
11/21/18
10:31
General news
Crude inventories for week of November 16 »

Crude oil inventories…

JNJ

Johnson & Johnson

$143.12

-3.32 (-2.27%)

10:30
11/21/18
11/21
10:30
11/21/18
10:30
Options
J&J puts active as shares see relative weakness »

J&J puts active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

10:30
11/21/18
11/21
10:30
11/21/18
10:30
General news
FX Action: The dollar »

FX Action: The dollar…

DE

Deere

$143.26

4.77 (3.44%)

10:29
11/21/18
11/21
10:29
11/21/18
10:29
Hot Stocks
Deere says U.S. farmers, dealers 'cautiously optimistic' »

Says record yields,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

AVGO

Broadcom

$229.32

1.63 (0.72%)

, VLKAY

Volkswagen

$0.00

(0.00%)

10:28
11/21/18
11/21
10:28
11/21/18
10:28
Periodicals
Breaking Periodicals news story on Broadcom, Volkswagen »

Broadcom said to settle…

AVGO

Broadcom

$229.32

1.63 (0.72%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

AMZN

Amazon.com

$1,520.59

24.99 (1.67%)

10:27
11/21/18
11/21
10:27
11/21/18
10:27
Periodicals
Amazon contacting some users about error that exposed emails, The Verge says »

Amazon has been emailing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

10:25
11/21/18
11/21
10:25
11/21/18
10:25
General news
U.S. leading index rose 0.1% to 112.1 in October, another record high »

U.S. leading index rose…

TLC

Taiwan Liposome

$0.00

(0.00%)

10:21
11/21/18
11/21
10:21
11/21/18
10:21
Syndicate
Taiwan Liposome opens at $6.06, IPO priced at $5.80 per share »

Taiwan Liposome (TLC)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

NVDA

Nvidia

$150.33

1.19 (0.80%)

10:20
11/21/18
11/21
10:20
11/21/18
10:20
Technical Analysis
Technical Take: Nvidia goes negative on the day »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 10

    Dec

10:20
11/21/18
11/21
10:20
11/21/18
10:20
General news
U.S. October existing home sales bounced 1.4% to 5.220 M »

U.S. October existing…

JD

JD.com

$20.24

0.75 (3.85%)

10:20
11/21/18
11/21
10:20
11/21/18
10:20
Options
Third day of call buying in JD »

Third day of call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:20
11/21/18
11/21
10:20
11/21/18
10:20
General news
Treasury Action: yields steadied above lows »

Treasury Action: yields…

10:20
11/21/18
11/21
10:20
11/21/18
10:20
General news
The Michigan sentiment drop »

The Michigan sentiment…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
11/21/18
11/21
10:17
11/21/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
11/21/18
11/21
10:16
11/21/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
11/21/18
11/21
10:15
11/21/18
10:15
General news
Breaking General news story  »

Week of 11/16 EIA…

WDC

Western Digital

$46.68

0.99 (2.17%)

10:10
11/21/18
11/21
10:10
11/21/18
10:10
Options
Western Digital weekly calls active as shares gain 3% »

Western Digital weekly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

10:10
11/21/18
11/21
10:10
11/21/18
10:10
General news
U.S. consumer sentiment fell 1.1 points to 97.5 in the final November print »

U.S. consumer sentiment…

BGNE

BeiGene

$126.50

0.63 (0.50%)

, GMDA

Gamida Cell

$9.50

(0.00%)

10:09
11/21/18
11/21
10:09
11/21/18
10:09
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

BGNE

BeiGene

$126.50

0.63 (0.50%)

GMDA

Gamida Cell

$9.50

(0.00%)

MRKR

Marker Therapeutics

$6.37

0.11 (1.76%)

ARCE

Arco Platform

$22.65

(0.00%)

NVT

nVent Electric

$24.43

0.25 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 01

    Dec

  • 03

    Dec

  • 07

    Dec

LOW

Lowe's

$86.80

0.65 (0.75%)

, GS

Goldman Sachs

$193.69

2.35 (1.23%)

10:09
11/21/18
11/21
10:09
11/21/18
10:09
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

LOW

Lowe's

$86.80

0.65 (0.75%)

GS

Goldman Sachs

$193.69

2.35 (1.23%)

CS

Credit Suisse

$11.93

0.21 (1.79%)

SWGAY

Swatch Group

$0.00

(0.00%)

LNT

Alliant Energy

$44.64

-0.62 (-1.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.